<DOC>
	<DOC>NCT01483833</DOC>
	<brief_summary>To evaluate the safety and efficacy of topical 0.5% S-MPEC cream vs. placebo cream (applied twice daily for 14 days) in the treatment of Grade I - III hemorrhoids.</brief_summary>
	<brief_title>Efficacy Study of Iferanserin to Treat Hemorrhoids</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhoids</mesh_term>
	<criteria>Age 18 years or older Diagnosis of grade I III hemorrhoids with bleeding episodes of at least every other day during the last two weeks before enrollment in the study. Patients signing the Informed Consent form. Patients with protruding or irreducible hemorrhoids (grade IV). Patients with anal fistulas, periproctitis or hemorrhagic diathesis Patients with current history of Type I or Type II diabetes mellitus. Patients with severe hepatic, renal or cardiovascular disorders. Patients with any type of infectious disease. Patients who have been involved with another experimental drug trial within the past 30 days. Patients presently diagnosed with cancer. Patients who have known alcohol and drug abuse. Patients who require the use of suppositories. Patients with blood or urine laboratory values outside the normal limits or those with values considered abnormal in the opinion of the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>